- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01680302
Effect of 3 Years of Exercise on Development of Atrial Fibrillation
September 16, 2022 updated by: Norwegian University of Science and Technology
Effect of 3 Years of Exercise on Development of Atrial Fibrillation - A "Generation 100" Substudy
This is a substudy of "Generation 100".
In that study, 4000 healthy persons between 70 and 75 will be randomised to a moderate intensity training group, a high intensity training group or control group, with 3 years of exercise.
The investigators will follow these persons and register all who develop atrial fibrillation during these 3 years, and at follow-up after ended intervention to see if there is differences in the number of persons who develop atrial fibrillation in the 3 groups.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
1567
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Trondheim, Norway, 7491
- Norwegian University of Science and Technology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
70 years to 75 years (Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participating in the "Generation 100" study
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High intensity exercise
High intensity exercise(Borg 16) in intervals.
|
|
|
Experimental: Moderate intensity exercise
Moderate intensity exercise 3 times a week.
|
|
|
Experimental: Control group
Exercise on their own.
Follow current guidelines.
|
Advised to follow current guidelines for physical activity, but exercise on their own.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of persons who develop atrial fibrillation during the 3 year intervention period
Time Frame: 3 years
|
People who already have the diagnosis before randomisation will not be counted.
|
3 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of persons who develop atrial fibrillation during the 6 years after randomisation
Time Frame: 6 years
|
6 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Chair: Jan Paal Loennechen, PhD, St. Olavs Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2012
Primary Completion (Anticipated)
June 1, 2023
Study Completion (Anticipated)
June 1, 2026
Study Registration Dates
First Submitted
September 4, 2012
First Submitted That Met QC Criteria
September 6, 2012
First Posted (Estimate)
September 7, 2012
Study Record Updates
Last Update Posted (Actual)
September 19, 2022
Last Update Submitted That Met QC Criteria
September 16, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012/978b-2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atrial Fibrillation
-
Medtronic Cardiac Ablation SolutionsRecruitingParoxysmal Atrial Fibrillation (PAF) | Persistent Atrial Fibrillation | Atrial Fibrillation (AF)Australia, United States, France, Belgium, Switzerland, Czechia
-
Boston Scientific CorporationRecruitingAtrial Fibrillation (AF) | Persistant Atrial FibrillationUnited States, Spain, Belgium, France, Netherlands, Germany, Hong Kong
-
China National Center for Cardiovascular DiseasesRecruitingAtrial Fibrillation Ablation | Atrial Fibrillation (AF) | Radiofrequency Catheter Ablation | Atrial Fibrillation Recurrent | Pulsed Field AblationChina
-
Ablacon, Inc.CompletedArrhythmias, Cardiac | Atrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Longstanding Persistent Atrial FibrillationGermany
-
CortexAblacon, Inc.Active, not recruitingAtrial Fibrillation | Arrhythmias, Cardiac | Arrhythmia | Atrial Flutter | Atrial Fibrillation, Persistent | Atrial Tachycardia | Atrial Arrhythmia | Atrial Fibrillation Paroxysmal | Atrial Fibrillation, Paroxysmal or PersistentUnited States, Belgium, Netherlands, Czechia
-
AtriCure, Inc.Active, not recruitingPersistent Atrial Fibrillation | Atrial Fibrillation (AF) | Longstanding Persistent Atrial FibrillationUnited States
-
Boston Scientific CorporationRecruitingParoxysmal Atrial Fibrillation | Persistent Atrial FibrillationHong Kong, Czechia, Croatia, Taiwan
-
Medtronic Cardiac Ablation SolutionsNot yet recruitingParoxysmal Atrial Fibrillation (PAF) | Persistent Atrial Fibrillation
-
University Medical Centre LjubljanaEnrolling by invitationPersistent Atrial Fibrillation | Persistent Atrial Fibrillation LongstandingSlovenia
-
Maastricht University Medical CenterRWTH Aachen UniversityUnknownAtrial Fibrillation (Paroxysmal) | Atrial Fibrillation Recurrent | Atrial Fibrillation Common Gene VariantsNetherlands
Clinical Trials on Moderate intensity exercise
-
Aksaray University Training and Research HospitalCompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNFTurkey (Türkiye)
-
Swinburne University of TechnologyNational Sports Institute of MalaysiaCompletedHealthy | Overweight | Physical InactivityMalaysia
-
Marquette UniversityRecruitingQuality of Life | Pain | Aging | Pain Management | Exercise Training | Aerobic Exercise | Sports | Athlete | Strength Training | Sports Medicine | Strength Training EffectsUnited States
-
University of Texas Southwestern Medical CenterAmerican Heart Association; Biotronik SE & Co. KG; American College of Sports...CompletedHypertrophic CardiomyopathyUnited States
-
Georgia State UniversityEmory UniversityWithdrawn
-
Yale UniversityNot yet recruitingObsessive-Compulsive Disorder (OCD)United States
-
HealthPartners InstituteRecruitingMyasthenia GravisUnited States
-
Christal L BadourNational Institute of Mental Health (NIMH); University of Texas at AustinRecruiting
-
Cardiff Metropolitan UniversityCardiff UniversityCompletedPolycystic Ovary Syndrome | Exercise | Cerebrovascular CirculationUnited Kingdom
-
University of MiamiCompletedSedentary LifestyleUnited States